The severity of the COVID-19 pandemic could justify the use of human challenge studies in vaccine development, and their careful use may be worth considering if they’re conducted the right way, a medical ethics expert argued. Read More

To support research teams at sites struggling with the impact of COVID-19, the Association of Clinical Research Professionals (ACRP) has set up a Clinical Research Site Sustainability Fund to provide grants to sites for continuing education and career development resources. Read More

A new survey of investigator sites reveals approximately 69 percent of respondents said lockdown measures have impacted their ability to conduct ongoing trials and 78 percent said COVID-19 has affected their ability to start new trials. Read More

The COVID-19 Collaboration Platform (COVIDCP), a new initiative from universities and clinical trial organizations across the U.S., will bring together research teams who are working on vaccines and treatments for COVID-19. Read More

Pharma companies and CROs are experiencing ups and downs in the second quarter of 2020, with some fighting to keep their trials afloat amidst pandemic uncertainties while others are slowly getting back on track. Read More

A working group of the World Health Organization (WHO) has indicated its support of COVID-19 vaccine challenge studies, but made it clear that those trials must meet eight conditions for them to be considered. Read More